407 related articles for article (PubMed ID: 15814836)
1. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD
J Am Soc Nephrol; 2005 May; 16(5):1350-9. PubMed ID: 15814836
[TBL] [Abstract][Full Text] [Related]
2. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
3. Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen.
Bolton WK; Chen L; Hellmark T; Wieslander J; Fox JW
J Am Soc Nephrol; 2005 Sep; 16(9):2657-66. PubMed ID: 16049074
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of the PD-1/PDL-1 T-cell co-inhibitory pathway is effective in treatment of experimental autoimmune glomerulonephritis.
Reynolds J; Sando GS; Marsh OB; Salama AD; Evans DJ; Cook HT; Pusey CD
Nephrol Dial Transplant; 2012 Apr; 27(4):1343-50. PubMed ID: 21965585
[TBL] [Abstract][Full Text] [Related]
5. Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis.
Reynolds J; Haxby J; Juggapah JK; Evans DJ; Pusey CD
Clin Exp Immunol; 2009 Feb; 155(2):311-9. PubMed ID: 19040602
[TBL] [Abstract][Full Text] [Related]
6. A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis.
Chen L; Hellmark T; Pedchenko V; Hudson BG; Pusey CD; Fox JW; Bolton WK
J Am Soc Nephrol; 2006 Nov; 17(11):3076-81. PubMed ID: 17005930
[TBL] [Abstract][Full Text] [Related]
7. Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis.
Reynolds J; Abbott DS; Karegli J; Evans DJ; Pusey CD
Am J Pathol; 2009 Jun; 174(6):2202-10. PubMed ID: 19406992
[TBL] [Abstract][Full Text] [Related]
8. Strain susceptibility to active induction and passive transfer of experimental autoimmune glomerulonephritis in the rat.
Reynolds J; Albouainain A; Duda MA; Evans DJ; Pusey CD
Nephrol Dial Transplant; 2006 Dec; 21(12):3398-408. PubMed ID: 16998225
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility to experimental autoimmune glomerulonephritis in the Wistar Kyoto rat.
Reynolds J; Cook PR; Behmoaras J; Smith J; Bhangal G; Tadros S; Tee J; Salama AD; Evans DJ; Aitman TJ; Cook HT; Pusey CD
Am J Pathol; 2012 May; 180(5):1843-51. PubMed ID: 22445570
[TBL] [Abstract][Full Text] [Related]
10. Expression and characterization of recombinant rat alpha 3(IV)NC1 and its use in induction of experimental autoimmune glomerulonephritis.
Ryan JJ; Reynolds J; Norgan VA; Pusey CD
Nephrol Dial Transplant; 2001 Feb; 16(2):253-61. PubMed ID: 11158397
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis.
Reynolds J; Khan SB; Allen AR; Benjamin CD; Pusey CD
Kidney Int; 2004 Oct; 66(4):1444-52. PubMed ID: 15458437
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Pusey CD
J Am Soc Nephrol; 2001 Jan; 12(1):61-70. PubMed ID: 11134251
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
14. Segregation of experimental autoimmune glomerulonephritis as a complex genetic trait and exclusion of Col4a3 as a candidate gene.
Reynolds J; Cook PR; Ryan JJ; Norsworthy PJ; Glazier AM; Duda MA; Evans DJ; Aitman TJ; Pusey CD
Exp Nephrol; 2002; 10(5-6):402-7. PubMed ID: 12381925
[TBL] [Abstract][Full Text] [Related]
15. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease.
Yang R; Cui Z; Hellmark T; Segelmark M; Zhao MH; Wang HY
Clin Immunol; 2007 Aug; 124(2):207-12. PubMed ID: 17556023
[TBL] [Abstract][Full Text] [Related]
16. Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with alpha3 chain of type IV collagen.
Abbate M; Kalluri R; Corna D; Yamaguchi N; McCluskey RT; Hudson BG; Andres G; Zoja C; Remuzzi G
Kidney Int; 1998 Nov; 54(5):1550-61. PubMed ID: 9844131
[TBL] [Abstract][Full Text] [Related]
17. Experimental autoimmune glomerulonephritis (EAG) induced by homologous and heterologous glomerular basement membrane in two substrains of Wistar-Kyoto rat.
Reynolds J; Mavromatidis K; Cashman SJ; Evans DJ; Pusey CD
Nephrol Dial Transplant; 1998 Jan; 13(1):44-52. PubMed ID: 9481714
[TBL] [Abstract][Full Text] [Related]
18. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
[TBL] [Abstract][Full Text] [Related]
19. The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice.
Hopfer H; Maron R; Butzmann U; Helmchen U; Weiner HL; Kalluri R
FASEB J; 2003 May; 17(8):860-8. PubMed ID: 12724345
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis.
Reynolds J; Norgan VA; Bhambra U; Smith J; Cook HT; Pusey CD
J Am Soc Nephrol; 2002 Feb; 13(2):359-369. PubMed ID: 11805163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
